Starting in January 2025, Rheumatology will be transitioning to an online-only publication, reducing our environmental impact while providing a more immersive and immediate reading experience for you. Moving Rheumatology online-only demonstrates our commitment to disseminating leading research while allowing us to enhance the content, interactivity, and accessibility of the journal. There will be no colour charges for papers submitted after 1 September 2024.
Scholar9.com is a peer-review platform that hosts journals from across the globe. Please note that we do not own any of the journals hosted on the platform.
Services for Journal Owners:
Our platform enables journal owners to send articles for peer review to users who have registered via https://scholar9.com/register and have consented to serve as reviewers for multiple journals. Additionally, we offer an indirect manuscript submission system for journals that are claimed and actively managed by their respective owners on Scholar9.com.
Indexing and Contact Detail:
For accurate information about the indexing status of journals (in databases such as UGC CARE, Scopus, or Web of Science) and contact details, users must refer to the respective official websites.
Limitations of Responsibility:
Scholar9 is not responsible for indexing claims, manuscript acceptance/rejection, refunds of article processing charges, or any stage of the final publication process. Users are strongly advised to verify all information provided on the platform independently.
Resolution of Disputes:
Scholar9.com disclaims liability for disputes related to indexing claims, publication decisions, or other journal-specific matters. Users are encouraged to contact the respective journal owners directly for detailed information and clarifications.
True scholar network
